PATENT CLAIM ANALYSIS

Application Number: 16081902
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["514", "064000"]

Abstract:
Compounds, pharmaceutical formulations, and methods of treating bacterial infections are disclosed.

Claim (Index 3):
The compound of a preceding claim, or a salt or a hydrate or a solvate thereof, wherein said Z is selected from the group consisting of substituted or unsubstituted benzoxaborole, substituted or unsubstituted pyridinyloxaborole, substituted or unsubstituted benzoxaborininol, substituted or unsubstituted benzoxazaborininol, substituted or unsubstituted benzodiazaborininol, substituted or unsubstituted oxaborole, and substituted or unsubstituted dihydrobenzoazaborinine.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 97.0
- Lexical Diversity: 1.07692
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16081904', '16072278', '12306137', '14576718', '10422401']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7711041022525955
- 35 USC 102 Novelty (BERT): 0.5803701103176477
- Combined Prediction Score: 0.7520307030591007
- Mean Citation Score: 275.613584
- Max Citation Score: 475.27502
- Similarity Product: 403.63595979613785

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test